Glide™ Technology | Applications

By providing a way to quickly, cleanly and simply inject solid formulations of drugs and vaccines directly through the skin, the Glide technology opens up a whole new range of therapeutic options for new and existing treatments.

The needle-free Glide technology is an advanced delivery system, bringing injection technology into the 21st century. It presents opportunities to improve the delivery of drugs and vaccines to meet the following medical needs:

Biologic drugs	For protein-based therapeutics that cannot be taken orally, Glide offers a means to inject stable, solid formulations E.g. insulin, erythropoietin
Proprietary & generic drugs (novel or existing)	Opportunity to deliver stable solid formulations through the skin, improving drug delivery; offers product differentiation and patent extension options E.g. interferon alpha, interferon beta
Self administered drugs	Quick, easy, clean and safe to use at home with minimal training; no sharps disposal required and stable solid formulation may not require refrigeration E.g. human growth hormone, migraine treatments
Vaccines	Solid injection requires no needle and avoids need for expensive and complicated packaging to transport fluid; solid formulation may not require refrigeration; easy large scale, low cost manufacturing potential E.g. hepatitis B, measles, tuberculosis, influenza
Emergency medicines	Quick, easy and clean administration, can be carried out with minimal training; easy to store and carry, with long-term stability E.g. adrenalin, glucagon
Biodefence	Quick, easy and clean administration with minimal training; low cost manufacture on a large scale; stable formulations can be stockpiled E.g. smallpox and influenza vaccines
Developing world healthcare challenges	Heat stable formulations (no cold-chain required); low cost manufacture on large scale; quick, easy and clean administration with minimal training E.g. vaccines, paediatric formulations